Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12123880 Methods for detecting AAV

Patent 12123880 was granted and assigned to Genzyme on October, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Genzyme
Genzyme
0
Date Filed
May 22, 2023
0
Date of Patent
October 22, 2024
0
Patent Applicant
Genzyme
Genzyme
0
Patent Application Number
18321542
0
Patent Citations
‌
US Patent 9169299 AAV capsid proteins for nucleic acid transfer
0
‌
US Patent 11698377 Methods for detecting AAV
0
‌
US Patent 9441244 Mutant adeno-associated virus virions and methods of use thereof
0
‌
US Patent 6989264 Methods for generating high titer helper-free preparations of released recombinant AAV vectors
0
‌
US Patent 7588772 AAV capsid library and AAV capsid proteins
0
‌
US Patent 7629322 AAV vector for gene therapy
0
‌
US Patent 8137948 Methods for producing preparations of recombinant AAV virions substantially free of empty capsids
0
‌
US Patent 8283151 Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes
0
Patent Inventor Names
Catherine O'Riordan
0
Kate Zhang
0
Xiaoying Jin
0
Lin Liu
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12123880
0
Patent Primary Examiner
‌
Xiaoyun R Xu
0

Find more entities like US Patent 12123880 Methods for detecting AAV

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.